Notice of Kidney Interagency Coordinating Committee Meeting, 49252 [2015-20219]

Download as PDF 49252 Federal Register / Vol. 80, No. 158 / Monday, August 17, 2015 / Notices National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01). Date: September 10, 2015. Time: 12:30 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Room 3F100, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Louis A. Rosenthal, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Rm 3G42B, National Institutes of Health/ NIAID, 5601 Fishers Lane, MSC–79823, Bethesda, MD 20892–9823, (240) 669–5070, rosenthalla@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 12, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–20211 Filed 8–14–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES mstockstill on DSK4VPTVN1PROD with NOTICES National Institutes of Health Notice of Kidney Interagency Coordinating Committee Meeting The Kidney Interagency Coordinating Committee (KICC) will hold a meeting on September 25, 2015, on the pharmacist’s role in chronic kidney disease care. The meeting is open to the public. SUMMARY: VerDate Sep<11>2014 16:57 Aug 14, 2015 Jkt 235001 The meeting will be held on September 25, 2015, 9 a.m. to 12 p.m. Individuals wanting to present oral comments must notify the contact person at least 10 days before the meeting date. ADDRESSES: The meeting will be held in the Natcher Conference Center on the NIH Campus at 9000 Rockville Pike, Bethesda, MD 20894. FOR FURTHER INFORMATION CONTACT: For further information concerning this meeting, contact Dr. Andrew S. Narva, Executive Secretary of the Kidney Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 31A, Room 9A27, MSC 2560, Bethesda, MD 20892– 2560, telephone: 301–594–8864; FAX: 301–480–0243; email: nkdep@ info.niddk.nih.gov. DATES: DEPARTMENT OF HEALTH AND HUMAN SERVICES The KICC, chaired by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), comprises members of the Department of Health and Human Services and other federal agencies that support kidney-related activities, facilitates cooperation, communication, and collaboration on kidney disease among government entities. KICC meetings, held twice a year, provide an opportunity for Committee members to learn about and discuss current and future kidney programs in KICC member organizations and to identify opportunities for collaboration. The September 25, 2015 KICC meeting will focus on the pharmacist’s role in chronic kidney disease care. Any member of the public interested in presenting oral comments to the Committee should notify the contact person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives or organizations should submit a letter of intent, a brief description of the organization represented, and a written copy of their oral presentation in advance of the meeting. Only one representative of an organization will be allowed to present; oral comments and presentations will be limited to a maximum of 5 minutes. Printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the Committee by forwarding their statement to the contact person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Because of time constraints for the SUPPLEMENTARY INFORMATION: PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 meeting, oral comments will be allowed on a first-come, first-serve basis. Members of the public who would like to receive email notification about future KICC meetings should send a request to nkdep@info.niddk.nih.gov. Dated: August 4, 2015. Camille M. Hoover, Executive Officer, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. [FR Doc. 2015–20219 Filed 8–14–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Predoctoral Training Programs in Big Data Science. Date: September 24, 2015. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Feng Tao, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive Room 6184, MSC 7849, Bethesda, MD 20892, (301) 451–3940, feng.tao@nih.gov. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group, Neurotransporters, Receptors, and Calcium Signaling Study Section. Date: September 28–29, 2015. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Monaco, 700 F Street NW., Washington, DC 20001. Contact Person: Peter B Guthrie, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4182, MSC 7850, Bethesda, MD 20892, (301) 435– 1239, guthriep@csr.nih.gov. E:\FR\FM\17AUN1.SGM 17AUN1

Agencies

[Federal Register Volume 80, Number 158 (Monday, August 17, 2015)]
[Notices]
[Page 49252]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-20219]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Kidney Interagency Coordinating Committee Meeting

SUMMARY: The Kidney Interagency Coordinating Committee (KICC) will hold 
a meeting on September 25, 2015, on the pharmacist's role in chronic 
kidney disease care. The meeting is open to the public.

DATES: The meeting will be held on September 25, 2015, 9 a.m. to 12 
p.m. Individuals wanting to present oral comments must notify the 
contact person at least 10 days before the meeting date.

ADDRESSES: The meeting will be held in the Natcher Conference Center on 
the NIH Campus at 9000 Rockville Pike, Bethesda, MD 20894.

FOR FURTHER INFORMATION CONTACT: For further information concerning 
this meeting, contact Dr. Andrew S. Narva, Executive Secretary of the 
Kidney Interagency Coordinating Committee, National Institute of 
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 
31A, Room 9A27, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-594-
8864; FAX: 301-480-0243; email: nkdep@info.niddk.nih.gov.

SUPPLEMENTARY INFORMATION: The KICC, chaired by the National Institute 
of Diabetes and Digestive and Kidney Diseases (NIDDK), comprises 
members of the Department of Health and Human Services and other 
federal agencies that support kidney-related activities, facilitates 
cooperation, communication, and collaboration on kidney disease among 
government entities. KICC meetings, held twice a year, provide an 
opportunity for Committee members to learn about and discuss current 
and future kidney programs in KICC member organizations and to identify 
opportunities for collaboration. The September 25, 2015 KICC meeting 
will focus on the pharmacist's role in chronic kidney disease care.
    Any member of the public interested in presenting oral comments to 
the Committee should notify the contact person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present; oral 
comments and presentations will be limited to a maximum of 5 minutes. 
Printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
Committee by forwarding their statement to the contact person listed on 
this notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person. Because of time constraints for the meeting, 
oral comments will be allowed on a first-come, first-serve basis.
    Members of the public who would like to receive email notification 
about future KICC meetings should send a request to 
nkdep@info.niddk.nih.gov.

    Dated: August 4, 2015.
Camille M. Hoover,
Executive Officer, National Institute of Diabetes and Digestive and 
Kidney Diseases, National Institutes of Health.
[FR Doc. 2015-20219 Filed 8-14-15; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.